ACTINIUM PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $73.5M | $77.8M |
| FY2022 | — | $66.5M | $108.9M |
| FY2023 | — | $36.4M | $76.7M |
| FY2024 | — | $32.8M | $72.9M |
| FY2025 | — | $7.8M | $48.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $73.5M | $77.8M |
| FY2022 | — | $66.5M | $108.9M |
| FY2023 | — | $36.4M | $76.7M |
| FY2024 | — | $32.8M | $72.9M |
| FY2025 | — | $7.8M | $48.0M |